Literature DB >> 10064613

Glucocorticoids inhibit serum depletion-induced apoptosis in T lymphocytes expressing Bcl-2.

S T Huang1, J A Cidlowski.   

Abstract

Depletion of growth factors and glucocorticoids are known to induce apoptosis and inhibit growth in T lymphocytes. We have examined the effect of Bcl-2 expression on the cellular response to growth factor depletion in the presence or absence of glucocorticoids. Cell growth was determined by cell counting and viability was quantitated by dye exclusion. Apoptosis was evaluated by flow cytometry, analysis of DNA integrity, and enzymatic determination of caspase-3-like activity. Serum depletion and glucocorticoid administration inhibited cell growth and stimulated apoptosis in Bcl-2 negative cells. Cotreatment with both stimuli had additive effects on apoptosis but not on inhibition of cell growth. Bcl-2 expression abrogated the repressive effect of glucocorticoids on apoptosis but not on cell growth. In contrast, neither apoptosis nor growth inhibition induced by serum depletion of cells was blocked by Bcl-2 expression. However, glucocorticoid treatment of Bcl-2-overexpressing cells protected them from apoptosis induced by serum depletion. Glucocorticoid protection of Bcl-2-overexpressing cells from serum depletion-induced apoptosis was mimicked by other inducers of apoptosis, which act to inhibit protein synthesis. These data suggest that Bcl-2 expression can switch the effect of glucocorticoids from proapoptotic to antiapoptotic when lymphocytes expressing Bcl-2 are exposed to other apoptotic stimuli.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064613     DOI: 10.1096/fasebj.13.3.467

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma: effect of prior corticosteroid therapy.

Authors:  Elena Kan; Itai Levy; Daniel Benharroch
Journal:  Virchows Arch       Date:  2009-09-09       Impact factor: 4.064

2.  Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.

Authors:  U K Messmer; C Pereda-Fernandez; M Manderscheid; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

4.  Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways.

Authors:  U K Messmer; G Winkel; V A Briner; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.

Authors:  Rama Yerramasetti; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

6.  Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.

Authors:  S Sengupta; J L Vonesch; C Waltzinger; H Zheng; B Wasylyk
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

7.  Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.

Authors:  Sastry Gollapudi; Suman Jaidka; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

8.  Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency.

Authors:  TingTing Tseng; WuChing Uen; JenChih Tseng; ShaoChen Lee
Journal:  Oncotarget       Date:  2017-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.